Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Elysium Health Announces the Launch of Creatine+, a First-of-Its-Kind Longevity-Focused Creatine System Designed to Support Strength, Recovery, and Cognition

      Working with the world's leading scientists and clinicians, Elysium Health's™ mission is to to improve human healthspan and lifespan by providing direct access to breakthroughs in longevity science. Learn more at elysiumhealth.com.

      News provided by

      Elysium Health

      Jun 15, 2026, 08:35 ET

      Share this article

      Share this article


      Developed with the advisement of Michael Fredericson, M.D., Co-Director of the Stanford Center on Longevity, Creatine+ uniquely combines creatine monohydrate with HMB and pomegranate polyphenols

      NEW YORK, June 15, 2026 /PRNewswire/ -- Elysium Health, Inc.™, the leading longevity science company, today announced the launch of CREATINE+™ by Elysium Health, a novel 3-in-1 creatine system formulated specifically for longevity that supports strength, recovery, and cognition. Developed with the advisement of Michael Fredericson, M.D., Co-Director of the Stanford Center on Longevity, Professor and Director of PM&R Sports Medicine at Stanford University, and Elysium Scientific Advisory Board member, Creatine+ uniquely combines three scientifically validated ingredients—creatine monohydrate, HMB (β-hydroxy β-methylbutyrate), and pomegranate polyphenols standardized to urolithin A precursors—to address multiple biological pathways involved in overall long-term health, including age-related muscle decline, physical function, and cognition.

      Continue Reading
      Based on 10 g creatine or 10 g creatine + 3 g HMB daily for 2 weeks, combined with resistance training (after 1-week loading phase). Adapted from Jówko et al., Nutrition. 2001.
      Based on 10 g creatine or 10 g creatine + 3 g HMB daily for 2 weeks, combined with resistance training (after 1-week loading phase). Adapted from Jówko et al., Nutrition. 2001.
      CREATINE+ is a novel 3-in-1 system formulated specifically for longevity that supports strength, recovery, and cognition. Developed with the advisement of Dr. Michael Fredericson, Co-Director of the Stanford Center on Longevity, Creatine+ uniquely combines three scientifically validated ingredients—creatine monohydrate, HMB, and urolithin A precursors—to address multiple biological pathways involved in long-term health, including age-related muscle decline, physical function, and cognition.
      CREATINE+ is a novel 3-in-1 system formulated specifically for longevity that supports strength, recovery, and cognition. Developed with the advisement of Dr. Michael Fredericson, Co-Director of the Stanford Center on Longevity, Creatine+ uniquely combines three scientifically validated ingredients—creatine monohydrate, HMB, and urolithin A precursors—to address multiple biological pathways involved in long-term health, including age-related muscle decline, physical function, and cognition.

      While creatine has long been recognized as one of the most studied and effective supplements for supporting muscle performance, it has recently gained widespread attention beyond athletes and fitness enthusiasts as research increasingly highlights the importance of muscle health for healthy aging, mobility, and longevity. By age 80, muscle mass decreases by approximately 30%, strength by 40%, and power by 50%. Creatine+ was designed to help address this challenge by uniquely combining ingredients that support muscle energetics, recovery, mitochondrial health, and cognition—the biological foundations of longevity and strength.

      Creatine+ features a comprehensive formulation designed specifically for longevity, not just athletic performance:

      • The highest purity micronized creatine monohydrate to support lean muscle, strength, and cognition
      • HMB, which works synergistically with creatine to support recovery and build muscle, as well as prevent muscle loss—meaning you keep more of the muscle you gain
      • Pomegranate polyphenols standardized to urolithin A precursors to support mitochondrial renewal and cellular energy production

      "Creatine has become one of my favorite supplements for supporting the maintenance of lean body mass, strength, and performance as we age, especially when paired with consistent resistance training," said Dr. Fredericson, Co-Director of the Stanford Center on Longevity and Elysium Scientific Advisory Board member. "What's unique about Creatine+ is that it optimizes for two critical components of athletic performance—both output and recovery. I highly recommend creatine for men and women, but women especially face distinct changes in muscle physiology, and Creatine+ offers targeted nutritional support for maintaining performance and vitality."

      Maintaining muscle health, mobility, and quality of life as we age requires more than simply building muscle. Creatine+ was designed to address multiple aspects of longevity by combining the highest-purity creatine monohydrate, micronized for superior solubility and bioavailability, with HMB—which supports recovery, helps reduce exercise-related muscle damage, and helps you maintain more of the muscle you build—and pomegranate polyphenols standardized to urolithin A precursors, which support mitochondrial health and cellular energy production. Clinical studies have shown that combining creatine with HMB can produce greater gains in lean muscle mass and strength than creatine alone. By pairing these ingredients with pomegranate-derived polyphenols that promote mitochondrial renewal, Creatine+ delivers a more comprehensive approach to supporting strength, recovery, cognition, and long-term muscle vitality.

      "Over the last several years, creatine has evolved from a supplement primarily associated with athletes and gym-goers into one of the most widely popular interventions for healthy aging," said Elysium CEO Eric Marcotulli. "That shift reflects a growing recognition that muscle health is one of the most important predictors of long-term health, independence, and quality of life. At Elysium, we have always focused on translating advances in longevity science into products that help people not just age better but live better. Creatine+ is a natural extension of that mission—a scientifically rigorous formulation designed to support strength today, and to help preserve physical function, resilience, and cognition over the long term."

      Creatine+ is available now at elysiumhealth.com.

      These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

      About Elysium Health™

      Elysium Health's™ mission is to solve the biggest challenges in health with science, to help people lead healthier lives. Working directly with the world's leading scientists and clinicians, Elysium Health™ is committed to translating critical advancements in aging research into health solutions people can access today. Elysium Health™ is backed by General Catalyst, Morningside Ventures, Breyer Capital, Mayo Clinic Ventures, and other notable investors. Learn more at elysiumhealth.com.

      SOURCE Elysium Health

      Modal title

      Also from this source

      Elysium Health™ Announces the Launch of Balance™, a First-of-Its-Kind Approach to Perimenopause and Menopause Support Grounded in Longevity Science

      Elysium Health™ Announces the Launch of Balance™, a First-of-Its-Kind Approach to Perimenopause and Menopause Support Grounded in Longevity Science

      Elysium Health, Inc.™, the leading longevity science company, today announced the launch of BALANCE™ by Elysium Health, a first-of-its-kind...

      Elysium Health™ Officially Opens The Elysium Longevity Institute™ (TELI), Establishing a New Standard for Longevity Medicine

      Elysium Health™ Officially Opens The Elysium Longevity Institute™ (TELI), Establishing a New Standard for Longevity Medicine

      Elysium Health, Inc.™, the leading longevity science company, today announced the opening of The Elysium Longevity Institute™ (TELI), marking the...

      More Releases From This Source

      Explore

      Health Care & Hospitals

      Health Care & Hospitals

      Supplementary Medicine

      Supplementary Medicine

      Fitness/Wellness

      Fitness/Wellness

      New Products & Services

      New Products & Services

      News Releases in Similar Topics

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.